文献速递腹部技术与安全MR

MRI评估的肝细胞癌瘤内脂肪的预后意义:一项亚洲与欧洲队列研究

Prognostic Implications of MRI-assessed Intratumoral Fat in Hepatocellular Carcinoma: An Asian and European Cohort Study.
PubMed 文献 · Radiology · 2024-01-01

这项回顾性队列研究纳入东亚和西欧两中心933例接受切除术的单发肝细胞癌患者,术前行增强MRI,由放射科医生独立评估瘤内脂肪。瘤内脂肪在亚洲和欧洲队列分别占30%和31%,与脂肪性肝炎型亚型、非周边廓清、强化包膜及马赛克架构相关;瘤内脂肪总体与预后无关,但亚洲队列中均匀瘤内脂肪与更长无复发生存和总生存相关。

要点

  • MRI评估的瘤内脂肪定义为「肿块内脂肪多于邻近肝」,均匀亚型为无马赛克及结节套结节架构。
  • 瘤内脂肪在脂肪性肝炎型肝细胞癌中更常见,并与非周边廓清、强化包膜、马赛克架构相关。
  • 亚洲队列中均匀瘤内脂肪与更长无复发生存(HR 0.60)和总生存(HR 0.33)相关。

核心结论

  • MRI评估的瘤内脂肪在脂肪性肝炎型肝细胞癌中更常见,并与非周边廓清、强化包膜及马赛克架构相关;瘤内脂肪总体无预后意义,但亚洲队列中均匀瘤内脂肪与更长无复发生存和总生存相关。

研究设计与样本

  • 回顾性队列研究,纳入东亚两所三级医院(2011年3月至2021年12月)连续成人单发肝细胞癌切除患者736例和西欧两所三级医院(2012年9月至2019年12月)207例,共933例,术前均行增强MRI,由各医院三名放射科医生独立评估。

关键影像表现/征象

  • 瘤内脂肪在亚洲队列检出30%(215/726)、欧洲队列31%(64/207)(P=.72);脂肪性肝炎型亚型、非周边廓清、强化包膜及马赛克架构在含瘤内脂肪的肿瘤中更常见(P值范围<.001至.04)。

诊断标准与关键数值

  • 依据LI-RADS v2018,瘤内脂肪定义为「肿块内脂肪多于邻近肝」,均匀亚型定义为瘤内脂肪「无马赛克及结节套结节架构」。

临床应用与阅片要点

  • 亚洲队列中均匀瘤内脂肪与更长无复发生存(HR 0.60;P=.009)和总生存(HR 0.33;P=.008)相关;瘤内脂肪总体与无复发生存或总生存无关(P值范围.48-.97)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background The clinicopathologic-radiologic and prognostic characteristics of intratumoral fat in hepatocellular carcinoma (HCC) are critical for personalized treatment but remain understudied. Purpose To investigate the clinicopathologic-radiologic associations and prognostic implications of MRI-assessed intratumoral fat in HCCs. Materials and Methods This retrospective cohort study included consecutive adult patients who underwent resection for solitary HCCs and preoperative contrast-enhanced MRI from two tertiary-care hospitals in East Asia (March 2011 to December 2021) and Western Europe (September 2012 to December 2019). MRI scans were independently evaluated by three radiologists at each hospital. Based on Liver Imaging Reporting and Data System (LI-RADS) version 2018, intratumoral fat was defined as "fat in mass more than adjacent liver," and the homogeneous subtype was defined as intratumoral fat "in absence of mosaic and nodule-in-nodule architecture." Recurrence-free survival (RFS) and overall survival (OS) were estimated using the Kaplan-Meier method and compared using the log-rank test. Cox regression analyses were conducted to identify factors associated with RFS and OS. Results A total of 933 patients were included in the Asian (n = 736; median age, 53 years [IQR, 45-62 years]; 626 male) and European (n = 207; median age, 64 years [IQR, 55-70 years]; 161 male) cohorts. MRI-assessed intratumoral fat was detected in 30% (215 of 726) and 31% (64 of 207) of patients in the Asian and European cohorts, respectively (P = .72). In both cohorts, the steatohepatitic subtype, nonperipheral washout, enhancing capsule, and mosaic architecture were more frequent in tumors with intratumoral fat (P value range, <.001 to .04). Intratumoral fat in general was not associated with RFS or OS in either cohort (P value range, .48-.97). However, in the Asian cohort, homogeneous intratumoral fat was associated with longer RFS (hazard ratio [HR], 0.60; P = .009) and OS (HR, 0.33; P = .008) in multivariable Cox regression analyses. Conclusion MRI-assessed intratumoral fat was more frequent in steatohepatitic HCCs and associated with nonperipheral washout, enhancing capsule, and mosaic architecture. Although intratumoral fat was generally nonprognostic, homogeneous intratumoral fat was associated with longer RFS and OS in the Asian cohort. Published under a CC BY 4.0 license. Supplemental material is available for this article. See also the editorial by Harmath in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Jiang H, Cannella R, Wu Z, et al. Prognostic Implications of MRI-assessed Intratumoral Fat in Hepatocellular Carcinoma: An Asian and European Cohort Study. Radiology. 2024. PMID: 39499179. doi:10.1148/radiol.233471

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。